CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells. Horvath RM, Brumme ZL, Sadowski I. J Virol 2023 Sep 6:e0092323. doi: 10.1128/jvi.00923.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Horvath RM, Brumme ZL, Sadowski I. CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells. J Virol 2023 Sep 6:e0092323. doi: 10.1128/jvi.00923.
PMID: 37671866